CD40 ligand (CD40L) is an essential effector cytokine for macrophage activation, dendritic cell licensing, and T cell-dependent antibody responses. Although CD40L is known to be made de novo following antigen recognition, several reports have described surface mobilization of 
Introduction
The tumor necrosis factor (TNF) family member CD40 ligand (CD40L, CD154) is a transmembrane protein expressed on the surface of activated CD4 + T cells, and triggers CD40-dependent activation of B cells, dendritic cells, and macrophages. 1 CD40L is recognized as an essential cytokine for both humoral and cell mediated immunity. 1,2 Dysregulation of the CD40L-CD40 pathway has been reported in several human diseases, including inflammatory bowel diseases, autoimmune diseases, and graft versus host disease. Blockade of CD40L holds promise for treating autoimmune diseases and inducing transplantation tolerance.
1-3
Surface expression of CD40L is tightly regulated. 1 After activation with peptide-pulsed antigen presenting cells (APCs), the de novo synthesis and surface expression of CD40L on naïve CD4 + T cells is detectable within 2 hours, peaks at 6 hours, and is significantly reduced by 24 hours after activation. 4 The presence of CD40 + cells prevents accurate detection of CD40L through CD40-induced endocytosis, shedding, and blocking by soluble CD40. [5] [6] [7] Importantly, the technical difficulties in detecting CD40L by flow cytometry can be overcome by using purified CD4 + T cells, 8, 9 employing a surface mobilization assay in which anti-CD40L monoclonal antibody (mAb)
is included in the culture during stimulation, 10-12 adding a blocking mAb to CD40, 13,14 or using CD40-deficient animals. 9 The studies that have relied on conventional staining methods for following stimulation with PMA plus ionomycin or immobilized anti-CD3 mAb. 15 The early surface expression of CD40L on CD4 + CD45RO + T cells is insensitive to cycloheximide (CHX), while the second phase of CD40L expression beginning at 1 hour after stimulation in both naïve and memory T cells is sensitive to CHX treatment. 15 Other groups have reported rapid and inducible surface expression of preformed CD40L in specialized subsets of effector CD4 + T cells including CD4 + CXCR5 + follicular B helper T cells, 16 P-selectin hi and P-selectin -L-selectin -effector CD4 + T cells, 17 synovial fluid CD4 + T cells from rheumatoid arthritis patients, 18 and memory CD4 + T cells from lupus prone, young, clinically healthy mice. 19 Recently, Lesley et al. reported the discovery of a different type of preformed CD40L that is constitutively sorted to the cell surface in naïve CD4 + T cells and natural regulatory T cells. 9 However, a systematic analysis of the existence and the surface mobilization of intracellular, preformed CD40L among naïve, effector, and memory CD4 + T cell populations in normal immune responses has not been
-
conducted.
The secretion of effector molecules from T cells occurs via the constitutive secretory pathway, in which newly synthesized proteins are released by exocytosis of small vesicles directly after Golgi processing, or the regulated secretory pathway, in which effector proteins are stored in intracellular vesicles until cells are stimulated. 20 For the latter pathway, secretory vesicles can be divided into at least two categories: specialized secretory vesicles that lack lysosomal markers (e.g., RANTES storage vesicles and CXCR3/1-storing granules) 21, 22 and "secretory lysosomes (SLs)", a heterogeneous group of organelles that share lysosomal markers and includes the lytic granules of cytolytic T lymphocytes. 23 Naïve T lymphocytes do not possess SLs, but acquire them upon activation. 23 Fas ligand (FasL, CD178), another member of the TNF family, is stored in SLs in both CD4 + and CD8 + activated T cells and is released to the cell surface upon T-cell receptor (TCR) signaling. 24 CTLA-4 (CD152) is also reported to be stored in SLs and is mobilized toward the contact site between T cells and APCs upon antigen recognition. [25] [26] [27] Experiments to determine if intracellular CD40L is stored in SLs have not been reported.
Here we show that stimulated surface mobilization of intracellular, preformed CD40L is a general property of effector and memory T helper 1 (Th1) cells, whether generated in vitro or in vivo. We show that preformed CD40L is stored in SLs and co-localizes more strongly with FasL 
Materials and Methods

Animals
Antibodies and reagents
PerCP-anti-CD4, biotin-anti-Vβ3, biotin-anti-CD62L, and labeled isotype controls were 
T cell priming
A mixture of one million AND T cells in an AND RAG-1 knockout spleen cell suspension, 40 million splenocytes from I-E k /MCC antigen-transgenic mice, and 12.5 µg of LPS (L6761;
Sigma-Aldrich, St. Louis, MO) in HBSS was injected intravenously into RAG-1 knockout mice.
In vivo-primed AND T cells were recovered from recipient spleens 14 days later. In vitro-primed effector CD4 + T cells were generated as described previously.
28
Flow cytometric analysis of CD40L expression
Three different methods (the conventional method, the surface mobilization assay, and intracellular staining) were used to detect CD40L, FasL, CTLA-4, and CD107a by flow cytometry.
For the conventional method, cells were stained with PE-labeled anti-CD40L mAb at 4°C for 15 min in staining buffer (PBS plus 2% FBS plus 0.1% NaN 3 ). For the surface mobilization assay, cells were blocked with anti-FcγRII/III antibody, and 10 µg/ml of PE-labeled anti-CTLA-4, we assessed the surface expression of CD40L upon stimulation with the surface mobilization assay.
In this assay, a relatively high concentration of PE-labeled anti-CD40L mAb (MR1; 10µg/ml) is included in a 30 minute culture to enhance the detection of CD40L by capturing CD40L that would otherwise be down-modulated by several mechanisms (endocytosis, shedding, etc.) following CD40 engagement. 10,11 Indeed, the surface mobilization assay revealed a significant amount of CD40L expression after a 30 minute stimulation with PMA plus ionomycin ( To address whether the rapid surface expression of CD40L is dependent on de novo protein synthesis, we examined the effect of cycloheximide (CHX) on rapid CD40L expression. Kinetic experiments with T cells pretreated with CHX showed that early CD40L expression from 5 to 30 min after stimulation is CHX resistant, while CD40L expression at 1 hour is partially sensitive (Fig.   1E ). Complete inhibition of IFN-γ production from T cells by CHX verified that protein synthesis was blocked (Fig.1F) . These results indicate that the mobilization of CD40L within 30 min after stimulation relies on intracellular, preformed CD40L rather than de novo synthesized CD40L. To extend these finding to more physiological conditions, we used antigen-pulsed APCs to stimulate the T cells, and found that antigenic stimulation for 30 minutes also induced the surface expression of preformed CD40L as well as CTLA-4 ( Fig. 1G ).
Next, we tested the existence of preformed CD40L in effector CD4 + T cells generated in vivo CD40L assessed by intracellular staining and the surface mobilization assay was higher in effector CD4 + T cells generated in vivo than in those generated in vitro (Fig. 1H) . These results indicate that preformed CD40L is a shared property of effector CD4 + T cells generated in vitro or in vivo.
CD40L is found in secretory lysosomes and co-localizes more strongly with FasL than with
CTLA-4
Yellin et al. 5 showed that ammonium chloride or chloroquine treatment of CD4 + T cells increased the amount of intracellular CD40L, suggesting that intracellular CD40L might be localized in an acidic, lysosomal compartment. Also, FasL, another TNF family member, is stored in SLs. 24 For personal use only. on October 3, 2017. by guest www.bloodjournal.org From   -1 6 -Therefore, we hypothesized that CD40L might exist in a lysosomal compartment in activated CD4 + T cells. Day 14 in vivo-generated effector CD4 + T cells were enriched by negative selection and then fixed, permeabilized and stained with anti-Vβ3 mAb and polyclonal anti-CD40L Ab together with antibodies to several cellular compartment markers. Transgenic T cells were identified based on Vβ3 staining by fluorescent microscopy (data not shown), and were subsequently analyzed for co-localization of CD40L with compartment markers by fluorescent microscopy as described in the Materials and Methods. As shown in Fig. 2 , CD40L staining showed a vesicular distribution and co-localized with the lysosome markers Lamp-2 (r =0.607 ± 0.021) and Cathepsin-D (r =0.636 ± 0.016). CD40L also weakly co-localized with a marker for endosomes (EEA1, r =0.317 ± 0.017) and a marker for the constitutive secretory pathway (β 2 -microglobulin, r =0.466 ± 0.018). CD40L did not co-localize with a Golgi marker, Giantin (r =0.095 ± 0.015). Statistical analysis confirmed that CD40L staining co-localized with the lysosomal markers more than any other markers (Fig. 2B) . Finally, the co-localization of CD40L
with FasL and CTLA-4 was compared in in vitro-generated effector CD4 + T cells. As shown in Fig.   3A , B, and E, CD40L co-localized more strongly with FasL (r =0.753 ± 0.010 (n= 25)) than with CTLA-4 (r =0.481 ± 0.018). The specificity of the polyclonal anti-CD40L Ab was confirmed by lack of staining of effector CD4 + T cells from CD40L-deficient TCR transgenic mice ( Fig. 3C and (Fig. 4A) . As expected, effector/memory CD4 + T cells had intracellular CD40L, and surprisingly, naïve CD4 + T cells also possessed intracellular CD40L (Fig. 4B ). In accordance with results from Lesley et al., 9 both naïve and effector/memory CD4 + T cells from CD40-deficient mice exhibited clear surface CD40L
For (Fig. 4D) , probably due to the lack of CD40-dependent down-modulation of surface CD40L on CD4 + T cells. Intracellular CD40L staining was also enhanced in CD40-deficient mice (Fig. 4E) the surface mobilization assay revealed that CD40L was sorted to the correct intracellular compartment independently of CD40 (Fig. 4F) . Staining of CD40L-deficient splenocytes confirmed the specificity of all three different staining methods for CD40L detection (Fig. 4G-I 
Virus-specific effector and memory CD4 + T cells rapidly express surface CD40L upon antigenic
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Discussion
CD40L is generally believed to be made de novo following antigen recognition, and to be transported to the surface by the constitutive secretory pathway. In this paper, we show that effector and memory CD4 + T cells also store preformed CD40L in SLs and mobilize it rapidly to the cell surface following antigen recognition. We show that inducible rapid surface expression of preformed CD40L is not limited to recently activated [15] [16] [17] or pathogenic 18, 19 T cell subsets, but is a general property of effector and memory Th1 cells. Although further work will need to be done to establish the functional significance of rapid, stimulated surface expression of preformed CD40L, these findings suggest a previously overlooked mechanism for effector and memory CD4 + T cells to activate APCs bearing specific antigen during brief interactions that are too short to allow de novo cytokine synthesis.
How does CD40L get to lysosomal compartments to be stored as preformed CD40L? 9 probably owing to efficient CD40-induced internalization and destruction of CD40L. 5, 18 Our data from normal and CD40-deficient mice suggests the existence of two distinct pools of intracellular CD40L in resting CD4 + T cells: one is sorted to the cell surface by constitutive secretion and is used by all CD4 + T cells, 9 and the other appears on the cell surface in response to external stimulation and is used by effector/memory but not naïve CD4 + T cells. Entry of CD40L
into the secretory compartment in effector/memory cells does not depend on CD40-induced internalization, because we observed increased intracellular CD40L, and surface mobilization of intracellular, preformed CD40L in effector/memory CD4 + T cells, even when the T cells were obtained from CD40-deficient animals (Fig. 4) following TCR triggering. 4 It is possible that IL-12 and IL-18 maintain the production of preformed CD40L during the acute phase of inflammation. In addition, IL-7 is a known survival factor for memory CD4 + T cells 40 and induces CD40L expression on CD4 + T cells. 41 Therefore, we speculate that IL-7 might not only provide the survival signal but also contribute to maintaining intracellular CD40L levels in memory CD4 + T cells.
We found that CD40L colocalizes with FasL more strongly than with CTLA-4 ( Fig. 3) , although both FasL and CTLA-4 are reported to exist in SLs. [24] [25] [26] [27] Incubation of unstimulated T cells with antibodies at 37°C for 30 minutes labeled CTLA-4 and CD107a much more effectively than CD40L and FasL (Fig. 1D) , which may be attributed to the cycling of CTLA-4 and CD107a between the endosomal compartment and the cell surface. 25, 42 The lack of participation of CD40L
and FasL in the endosomal recycling compartment may explain the weaker co-localization between CD40L and CTLA-4 that we describe here. Alternatively, this difference may reflect 
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